Distinguishing Migraine from Demyelinating Diseases like Multiple Sclerosis
Introduction to Diagnostic Considerations
- The American Academy of Neurology suggests that migraine does not cause focal, lateralized lesions that would appear as two distinct right-sided abnormalities developing over 2 years, a pattern that strongly suggests a demyelinating process like multiple sclerosis or another structural pathology requiring immediate investigation 1, 2
- The presence of two discrete right-sided lesions developing over 2 years demonstrates dissemination in time and space, hallmark criteria for multiple sclerosis diagnosis, as per the National Multiple Sclerosis Society 1, 2
Characteristic Lesions and Diagnostic Features
- Migraine-related white matter hyperintensities are typically bilateral, small (0.3-0.6 cm), punctate, and scattered in deep or periventricular white matter, not focal unilateral lesions, according to the American Headache Society 3
- MS lesions are focal, well-demarcated, ≥3 mm, and can be unilateral or asymmetric in distribution, as stated by the Multiple Sclerosis Association of America 5, 6
- Dissemination in time is demonstrated by new T2 or gadolinium-enhancing lesions on follow-up MRI, which two lesions in 2 years would fulfill, as per the National Institute of Neurological Disorders and Stroke 1, 2
Key Diagnostic Features to Evaluate
- Lesion location: MS favors periventricular regions perpendicular to corpus callosum ("Dawson's fingers"), juxtacortical U-fibers, and infratentorial areas, according to the American Academy of Neurology 6, 7
- Lesion characteristics: Ovoid shape, ≥3 mm size, well-demarcated borders, and gadolinium enhancement (if active), as stated by the European Federation of Neurological Societies 8, 5
- Spinal cord involvement: Short-segment focal lesions (<2 vertebral segments) in lateral/dorsal columns strongly support MS, as per the Consortium of Multiple Sclerosis Centers 5
Critical Distinguishing Features
| Feature | Migraine | MS/Demyelination |
|---|---|---|
| Distribution | Bilateral, symmetric | Can be unilateral, asymmetric [1, 6] |
| Size | Small (0.3-0.6 cm) | ≥3 mm, often larger [5, 6] |
| Location | Deep/periventricular white matter | Periventricular, juxtacortical, infratentorial, spinal cord [1, 6] |
| Progression | Stable or slowly progressive | New lesions demonstrate dissemination in time [1, 2] |
| Enhancement | No enhancement | May enhance with gadolinium if active [8, 5] |
| Cortical involvement | Absent | Present (leukocortical/intracortical) [6, 7] |
Recommended Diagnostic Approach
- Obtain brain and cervical/thoracic spine MRI with gadolinium to assess for additional lesions and enhancement patterns, as recommended by the American College of Radiology 1, 5
- Evaluate for dissemination in space: Look for lesions in ≥2 of 4 characteristic regions (periventricular, juxtacortical, infratentorial, spinal cord), according to the Multiple Sclerosis International Federation 1, 3
- CSF analysis for oligoclonal bands and elevated IgG index if MRI criteria are not fully met, as stated by the National Multiple Sclerosis Society 1